Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support

NCT02682381 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02682381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2016
Completion date
August 18, 2017
Enrollment
59 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

short bowel syndrome